Geneplus Technology

Geneplus Technology is a leading Chinese precision oncology company specializing in next-generation sequencing (NGS) and liquid biopsy technologies. Founded in 2014, the company provides comprehensive genomic profiling services and diagnostic kits for cancer screening, treatment selection, and minimal residual disease (MRD) monitoring. Geneplus operates a large-scale clinical laboratory network and has developed proprietary bioinformatics pipelines to analyze complex genetic data with high sensitivity. Their product portfolio includes several NMPA-approved NGS kits and sequencers, such as the Gene+Seq series, targeting various solid tumors. The company collaborates extensively with global pharmaceutical companies and clinical institutions to advance personalized medicine and companion diagnostics in the Chinese market.